Nader N. El-Chaar - Astellas Pharma Inc

基本信息

浏览量：6

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 18 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Real-world (RW) Survival and Outcomes with Androgen Receptor Pathway Inhibitor (ARPI) –doublet Therapy in Patients (pts) with De Novo Metastatic Castration-Sensitive Prostate Cancer (Mcspc)

Joshua Parrish,Thomas J. Polascik,Agnes Hong,Nader N. El-Chaar,Amanda Marie De Hoedt,Janet Kim,Claire Trustram Eve,Maelys Touya,Krishnan Ramaswamy,Lin Gu,Stephen J. Freedland

Journal of Clinical Oncologyno. 4_suppl (2024): 145-145

引用0浏览0引用

Resources to Address Challenges in First-Line Treatment Intensification in Metastatic Castration-Sensitive Prostate Cancer (mcspc): A Discrete Choice Experiment

Stacy Loeb,Neeraj Agarwal,Nader N. El-Chaar,Laura De Ruiter,Janet Kim, Jessica Mack,Christopher S. Bland, Sarah Rich-Zendel, Jay Sheldon, Jin Su Joo,Judith Dyson

Journal of Clinical Oncology（2024）

引用0浏览0引用

PD01-02 DIFFERENCES IN BARRIERS AND FACILITATORS TO FIRST-LINE TREATMENT INTENSIFICATION IN METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER BETWEEN UROLOGISTS AND ONCOLOGISTS: A SUB-ANALYSIS OF THE IMPLEMENT STUDY

Stacy Loeb,Neeraj Agarwal,Nader El-Chaar,Laura de Ruiter,Janet Kim, Jesse Mack, Christopher Bland, Sarah Rich-Zendel, Jin Su Joo,Judith Dyson

The Journal of Urology（2024）

引用0浏览0引用

Barriers and Facilitators to First-Line (1L) Treatment Intensification (TI) in Metastatic Castration-Sensitive Prostate Cancer (mcspc): the IMPLEMENT Study

Stacy Loeb,Neeraj Agarwal,Nader N. El-Chaar,Laura de Ruiter,Janet Kim, Jessica Mack,Christopher S. Bland, Sarah Rich-Zendel, Jin Su Joo,Judith Dyson

JOURNAL OF CLINICAL ONCOLOGY（2024）

引用2浏览0引用

Fatigue Management in Advanced Prostate Cancer: Real-World Insights from Qualitative Interviews with Patients

Stephen J. Freedland,Marty Chakoian, Ted Wells,Nader El-Chaar, Alexandra Colon,Dina Elsouda,Agnes Hong

Clinical genitourinary cancerno. 6 (2024): 102209-102209

引用0浏览0WOS引用

Real-world Prevalence of Adverse Events with First-Line Systemic Therapies among Patients with Metastatic Castration-Sensitive Prostate Cancer

Umang Swami, Bin Xie,Christopher Young,Krishnan Ramaswamy,Nader El-Chaar,Wei Gao,Hongbo Yang, Yao Wang,Lisa Mucha

The Prostate (2024)

引用1浏览0WOS引用

Characteristics and Treatment (tx) Patterns (txp) of High-Risk Biochemically Recurrent (HR-BCR) Non-Metastatic Castration-Sensitive Prostate Cancer in the Real-World by Race, Age, and Prostate-Specific Antigen (PSA) Doubling Time (PSADT)

Alicia K. Morgans,Lisa Mucha,Nader N. El-Chaar,Dina Elsouda,Krishnan Ramaswamy,Tammy Schuler,Bruce A. Feinberg,Prathamesh Pathak,Parisa Asgarisabet,Danielle Gentile,Stephen J. Freedland

Journal of Clinical Oncologyno. 16_suppl (2024): e17071-e17071

引用0浏览0引用

Real-world (RW) Prevalence of Adverse Events (aes) among Patients (pts) with Metastatic Castration-Sensitive Prostate Cancer (Mcspc)

Umang Swami, Bin Xie,Krishnan Ramaswamy,Nader N. El-Chaar,Wei Gao,Hongbo Yang, Yao Wang,Christopher Young,Lisa Mucha

JOURNAL OF CLINICAL ONCOLOGY（2023）

引用0浏览0引用

The Role of Physician Specialty in the Underutilization of Standard-of-Care Treatment Intensification in Patients with Metastatic Castration-sensitive Prostate Cancer

Umang Swami,Agnes Hong,Nader N. El-Chaar,Krishnan Ramaswamy, Brandon J. Diessner,Cori J. Blauer-Peterson,Rickard Sandin,David Nimke,Neeraj Agarwal

JOURNAL OF UROLOGY（2023）

引用10浏览0WOS引用

Outcomes of Patients (pts) with De Novo Metastatic Hormone-Sensitive Prostate Cancer (mhspc) Who Progressed to Metastatic Castration-Resistant Prostate Cancer (mcrpc): A Post-Hoc Analysis of the TRUMPET Registry

Daniel H. Shevrin,James Thomas Symanowski,Neal D. Shore,Daniel W. Lin,David Russell,Pavol Kral,Yi Song,Nader N. El-Chaar,Lawrence Ivan Karsh

JOURNAL OF CLINICAL ONCOLOGY（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn